Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXSL2400530	精蛋白人胰岛素混合注射液 (30R)	human insulin;isophane protamine human insulin	Injection	Biological Products(3.3)	New Drug Application	2024-08-10	Virtu Pharmako (Zhejiang) Co Ltd	view
CYSB2300234	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-12-21	Gan & Lee Pharmaceuticals	view
CYSB2300203	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-11-03	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
JYSZ2200062	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2022-11-08		view
JYSZ2200061	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2022-11-08		view
CYSB2200233	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2022-09-23	Gan & Lee Pharmaceuticals	view
JYSZ2200026	精蛋白人胰岛素混合注射液(30R)	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2022-06-24		view
CXSS2200010	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products(3.3)	New Drug Application	2022-01-28	Yichang HEC Changjiang Pharmaceutical Co Ltd	view
CYSB2200024	精蛋白人胰岛素混合注射液（30R)	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2022-01-26	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
CYSB2101284	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-12-10	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
JYSB2101173	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-11-29	Lilly France	view
JYSB2101175	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-11-29	Lilly France	view
CYSB2101244	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-10-28	Lilly Suzhou Pharmaceutical Co Ltd	view
CYSB2101174	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-09-02	Zhuhai United Laboratories Co Ltd	view
CYSB2101062	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-05-19	Zhuhai United Laboratories Co Ltd	view
JYSZ2100516	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-05-12		view
JYSZ2100508	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21		view
JYSZ2100506	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21		view
JYSZ2100507	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21		view
JYSZ2100505	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21		view